RFK Racing will feature sponsorship from Esperion Therapeutics in the NASCAR Cup Series in 2023, RFK announced Jan. 11.
The sponsorship kicks off via Brad Keselowski‘s No. 6, which will feature the company’s drug NEXLIZET for the Daytona 500.
Esperion will also adorn the No. 6 at the All-Star Race at North Wilkesboro Speedway and at Michigan International Speedway.
Additionally, fellow Esperion product NEXLETOL will be featured on Chris Buescher‘s No. 17 throughout the season: at Las Vegas Motor Speedway in the spring and at both Martinsville Speedway events.
According to an RFK release, the sponsorship deal is for multiple years.
“We’re thrilled to have Esperion, a company that is making waves in the pharmaceutical industry, on board with us,” Steve Newmark, president of RFK, said in a team release. “We look forward to working with Esperion to create engaging content around their two products in NEXLIZET and NEXLETOL and showcasing their debut on the No. 6 for the famed Daytona 500.
“We’re thankful to the team at Esperion and can’t wait to introduce them to the sport in a big way in 2023.”